Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells
article
OA: bronze
CC0
⤵ 132 in-corpus citations
AI-generated summary
Progesterone and progestational compounds were found to reduce TNFα-induced IL-8 production by inactivating NF-κB in endometriotic stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Comparative Pharmacology of Newer Progestogens via openalex
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro via openalex
- Dienogest via openalex
- Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis via openalex
- Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro via openalex
- Effect of hormonal agents on monocyte chemotactic protein-1 expression by endometrial epithelial cells of women with endometriosis via openalex
- Effect of Peritoneal Fluid From Endometriosis Patients on Endometrial Stromal Cell Proliferation In Vitro via openalex
- Effect of platelet-derived growth factor on endometrial stromal cell proliferation in vitro: a model for endometriosis? via openalex
- Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats via openalex
- Immunosuppressive effects of danazol in vitro via openalex
- Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex
- Pathogenetic Significance of Increased Levels of Interleukin-8 in the Peritoneal Fluid of Patients with Endometriosis via openalex
- Role of cytokines in endometriosis via openalex
- The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro via openalex
- Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression via openalex
- W6661376251 via openalex
- W1526719660 via openalex
- W2002687754 via openalex
- W2005247421 via openalex
- W2042642675 via openalex
- W2057869853 via openalex
- W2241768283 via openalex
- W6600426322 via openalex
- W6631531271 via openalex
- W10406553 via openalex
Cited by (50)
- Short-term safety of dienogest on bone mineral density in Iranian women with endometriosis: A cross-sectional study 2026
- Molecular pathogenesis of ovarian endometrioma: mechanistic insights and therapeutic implications 2025
- Azurocidin is associated with dienogest-resistance in ovarian endometriotic cysts 2024
- Hormonal Therapies before in vitro fertilization in women with endometriosis: The Minotaur's Labyrinth and the Ariadne's Thread 2024
- Hormonal Therapies before In-Vitro Fertilization in Women with Endometriosis 2024
- A Preliminary Investigation of the Roles of Endometrial Cells in Endometriosis Development via In Vitro and In Vivo Analyses 2024
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 8 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Serum leucine‐rich α2‐glycoprotein as a possible marker for inflammatory status in endometriosis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 8 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Resolution of the First Ukrainian endometriosis forum “Drug treatment for endometriosis-associated pelvic pain. The quality of a woman’s life” 2023
- Dienogest May Reduce Estradiol- and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture- and Mouse Model-Based Study 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Progestins 2022
- An Update on the Multifaceted Role of NF-kappaB in Endometriosis 2022
- Endometrial stromal PRMT5 plays a crucial role in decidualization by regulating NF-κB signaling in endometriosis 2022
- The issues of endometriosis hormonal treatment in reproductive age women 2022
- Effect of combined contraceptive pill on immune cell of ovarian endometriotic tissue 2021
- Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies† 2021
- IN-SILICO dynamic analysis of Sulawesi propolis as anti-endometriosis drug: Interaction study with TNF alpha receptor, NF-kB, estrogen receptor, progesterone receptor and prostaglandin receptor 2021
- Pathogenesis of Endometriosis: New Insights into Prospective Therapies 2021
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review 2021
- Progestogens and Endometriosis 2021
- Nuclear factor-kappa B signaling in endometriotic stromal cells is not inhibited by progesterone owing to an aberrant endoplasmic reticulum stress response: a possible role for an altered inflammatory process in endometriosis 2021
- Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis 2021
- Novel therapeutic strategy: antiinflammatory reagents 2021
- The effectiveness of therapy for endometriosis-associated pelvic pain resistant to surgical treatment 2021
- Role of estrogen and estrogen-related factors in endometriosis 2021
- A systematic review of toll-like receptors in endometriosis 2021
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis 2020
- New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone 2020
- A progestin isn’t a progestin: dienogest for endometriosis as a blueprint for future research – Review as a contribution for discussion - 2020
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:41.664291+00:00
License: CC0
· commercial use OK